Package 31722-834-31

{"route": ["ORAL"], "spl_id": "2b442999-71b5-88f6-e063-6394a90a9d6e", "openfda": {"nui": ["N0000175656", "N0000175459", "N0000009947"], "unii": ["NNU2O4609D"], "rxcui": ["485434", "485436"], "spl_set_id": ["01ec50a1-6c6c-46f0-8c74-73542b0a59c3"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (31722-834-30)", "package_ndc": "31722-834-30", "marketing_start_date": "20150821"}, {"sample": false, "description": "10 TABLET in 1 BLISTER PACK (31722-834-31)", "package_ndc": "31722-834-31", "marketing_start_date": "20150821"}, {"sample": false, "description": "100 TABLET in 1 CARTON (31722-834-32)", "package_ndc": "31722-834-32", "marketing_start_date": "20150821"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (31722-834-90)", "package_ndc": "31722-834-90", "marketing_start_date": "20150821"}], "brand_name": "Entecavir", "product_id": "31722-834_2b442999-71b5-88f6-e063-6394a90a9d6e", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "31722-834", "generic_name": "Entecavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR ANHYDROUS", "strength": "1 mg/1"}], "application_number": "ANDA205740", "marketing_category": "ANDA", "marketing_start_date": "20150821", "listing_expiration_date": "20261231"}